Biotechnology
The Biotechnology industry has a total of 587 stocks, with a combined market cap of $1.33 trillion and total revenue of $115.66 billion.
Market Cap
1.33T
Revenue
115.66B
Profits
-38.77B
PE Ratio
n/a
Profit Margin
-33.52%
Dividend Yield
0.04%
587 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 132.14B | -1.43% | 136,689 | 12.59B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 79.70B | -1.50% | 87,690 | 15.53B |
| 3 | ARGX | argenx SE | 62.97B | -0.87% | 58,808 | 5.32B |
| 4 | MRNA | Moderna, Inc. | 55.27B | -1.34% | 2,585,815 | 2.23B |
| 5 | RVMD | Revolution Medicines, Inc. | 45.04B | 1.36% | 199,803 | - |
| 6 | ONC | BeOne Medicines AG | 39.57B | -0.99% | 165,465 | 6.13B |
| 7 | RPRX | Royalty Pharma plc | 34.38B | -1.32% | 878,751 | 2.54B |
| 8 | ALNY | Alnylam Pharmaceuticals, Inc. | 33.94B | -2.48% | 329,357 | 4.80B |
| 9 | ROIV | Roivant Sciences Ltd. | 29.95B | -0.05% | 1,843,141 | 7.53M |
| 10 | INSM | Insmed Incorporated | 27.36B | 0.31% | 978,066 | 1.14B |
| 11 | INCY | Incyte Corporation | 25.25B | 0.14% | 100,906 | 5.82B |
| 12 | BNTX | BioNTech SE | 24.48B | -1.24% | 125,406 | 3.03B |
| 13 | GMAB | Genmab A/S | 20.11B | -0.81% | 489,680 | 4.13B |
| 14 | ASND | Ascendis Pharma A/S | 17.33B | -2.32% | 98,349 | 1.20B |
| 15 | JAZZ | Jazz Pharmaceuticals plc | 15.47B | -0.75% | 54,473 | 4.60B |
| 16 | BBIO | BridgeBio Pharma, Inc. | 14.54B | -0.48% | 262,799 | 713.07M |
| 17 | EXEL | Exelixis, Inc. | 14.15B | -0.99% | 195,601 | 2.44B |
| 18 | SMMT | Summit Therapeutics Inc. | 13.83B | 0.35% | 1,373,544 | - |
| 19 | CORT | Corcept Therapeutics Incorporated | 12.60B | 2.27% | 74,615 | 830.81M |
| 20 | BMRN | BioMarin Pharmaceutical Inc. | 12.50B | -0.11% | 313,350 | 3.41B |
| 21 | MDGL | Madrigal Pharmaceuticals, Inc. | 12.38B | 0.32% | 46,657 | 1.28B |
| 22 | HALO | Halozyme Therapeutics, Inc. | 12.19B | -0.82% | 132,290 | 1.66B |
| 23 | ARWR | Arrowhead Pharmaceuticals, Inc. | 12.04B | 0.15% | 220,306 | 669.50M |
| 24 | TECH | Bio-Techne Corporation | 11.34B | -0.03% | 816,907 | 1.22B |
| 25 | AXSM | Axsome Therapeutics, Inc. | 10.93B | 0.45% | 77,143 | 776.57M |
| 26 | KRYS | Krystal Biotech, Inc. | 10.27B | -1.21% | 32,588 | 440.48M |
| 27 | CYTK | Cytokinetics, Incorporated | 10.27B | -1.98% | 265,347 | 67.67M |
| 28 | ABVX | ABIVAX Société Anonyme | 10.24B | -0.77% | 155,980 | 5.67M |
| 29 | PRAX | Praxis Precision Medicines, Inc. | 9.83B | -0.10% | 74,752 | 7.46M |
| 30 | KYMR | Kymera Therapeutics, Inc. | 9.74B | 0.60% | 205,865 | 105.00M |
| 31 | PTGX | Protagonist Therapeutics, Inc. | 9.51B | 0.73% | 128,180 | 281.99M |
| 32 | IONS | Ionis Pharmaceuticals, Inc. | 9.30B | -1.34% | 562,874 | 874.09M |
| 33 | PCVX | Vaxcyte, Inc. | 8.82B | -1.76% | 178,446 | - |
| 34 | IBRX | ImmunityBio, Inc. | 8.66B | -1.39% | 2,146,650 | 165.79M |
| 35 | IMVT | Immunovant, Inc. | 8.11B | -0.76% | 96,108 | - |
| 36 | TGTX | TG Therapeutics, Inc. | 7.82B | -1.11% | 227,462 | 799.54M |
| 37 | SYRE | Spyre Therapeutics, Inc. | 7.77B | -2.91% | 172,596 | - |
| 38 | BLTE | Belite Bio, Inc | 7.56B | -2.63% | 60,872 | - |
| 39 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.93B | -1.17% | 75,139 | 239.92M |
| 40 | CAI | Caris Life Sciences, Inc. | 6.90B | -1.69% | 807,945 | 989.61M |
| 41 | SRRK | Scholar Rock Holding Corporation | 6.81B | -2.59% | 364,875 | - |
| 42 | MIRM | Mirum Pharmaceuticals, Inc. | 6.50B | 0.61% | 67,508 | 618.07M |
| 43 | CGON | CG Oncology, Inc. | 6.48B | -0.44% | 76,233 | 6.23M |
| 44 | TVTX | Travere Therapeutics, Inc. | 6.27B | 0.76% | 235,205 | 591.33M |
| 45 | ORKA | Oruka Therapeutics, Inc. | 6.17B | -1.19% | 45,003 | - |
| 46 | COGT | Cogent Biosciences, Inc. | 6.07B | -0.79% | 241,606 | - |
| 47 | DNTH | Dianthus Therapeutics, Inc. | 6.04B | -0.99% | 118,874 | 1.90M |
| 48 | LGND | Ligand Pharmaceuticals Incorporated | 5.74B | -0.25% | 40,420 | 290.54M |
| 49 | XENE | Xenon Pharmaceuticals Inc. | 5.70B | -1.13% | 48,883 | 7.50M |
| 50 | PTCT | PTC Therapeutics, Inc. | 5.70B | -0.73% | 105,933 | 1.01B |
| 51 | ERAS | Erasca, Inc. | 5.68B | -0.18% | 806,469 | - |
| 52 | CRSP | CRISPR Therapeutics AG | 5.20B | -1.88% | 317,994 | 13.39M |
| 53 | DFTX | Definium Therapeutics, Inc. | 5.12B | -0.24% | 214,279 | - |
| 54 | PBLS | Parabilis Medicines, Inc. | 4.85B | -1.28% | 55,765 | 148.00K |
| 55 | ACAD | ACADIA Pharmaceuticals Inc. | 4.79B | 0.73% | 167,015 | 1.14B |
| 56 | EWTX | Edgewise Therapeutics, Inc. | 4.69B | -1.44% | 100,311 | - |
| 57 | CELC | Celcuity Inc. | 4.51B | -0.99% | 114,346 | - |
| 58 | ELVN | Enliven Therapeutics, Inc. | 4.32B | -0.76% | 89,725 | - |
| 59 | MANE | Veradermics, Incorporated | 4.18B | -3.74% | 97,988 | - |
| 60 | RLAY | Relay Therapeutics, Inc. | 4.16B | -0.68% | 338,895 | 10.35M |
| 61 | TLX | Telix Pharmaceuticals Limited | 4.10B | 1.67% | 143,812 | 890.79M |
| 62 | TNGX | Tango Therapeutics, Inc. | 4.03B | 5.40% | 1,419,480 | 53.81M |
| 63 | VKTX | Viking Therapeutics, Inc. | 3.95B | 0.50% | 333,967 | - |
| 64 | LEGN | Legend Biotech Corporation | 3.86B | -2.78% | 223,254 | 1.27B |
| 65 | IOVA | Iovance Biotherapeutics, Inc. | 3.86B | -2.07% | 1,631,434 | 324.97M |
| 66 | TARS | Tarsus Pharmaceuticals, Inc. | 3.73B | -2.45% | 74,617 | 606.33M |
| 67 | IDYA | IDEAYA Biosciences, Inc. | 3.73B | -0.54% | 61,669 | 234.13M |
| 68 | DYN | Dyne Therapeutics, Inc. | 3.69B | -2.76% | 1,662,844 | - |
| 69 | RCUS | Arcus Biosciences, Inc. | 3.62B | -2.13% | 508,762 | 117.00M |
| 70 | ABCL | AbCellera Biologics Inc. | 3.59B | -3.19% | 548,342 | 66.17M |
| 71 | DNLI | Denali Therapeutics Inc. | 3.44B | -2.54% | 351,386 | 3.60M |
| 72 | QURE | uniQure N.V. | 3.18B | 0.37% | 255,560 | 18.67M |
| 73 | GPCR | Structure Therapeutics Inc. | 3.15B | 9.29% | 475,546 | - |
| 74 | CLDX | Celldex Therapeutics, Inc. | 3.08B | 0.26% | 109,565 | 158.00K |
| 75 | MBX | MBX Biosciences, Inc. | 3.02B | -0.60% | 65,216 | - |
| 76 | ARQT | Arcutis Biotherapeutics, Inc. | 3.01B | -1.93% | 305,402 | 463.98M |
| 77 | IMNM | Immunome, Inc. | 2.98B | -1.98% | 99,499 | 4.02M |
| 78 | IRON | Disc Medicine, Inc. | 2.92B | -1.10% | 29,179 | - |
| 79 | NAMS | NewAmsterdam Pharma Company N.V. | 2.86B | -6.63% | 225,610 | 7.12M |
| 80 | ZLAB | Zai Lab Limited | 2.84B | -0.35% | 110,403 | 449.61M |
| 81 | SLS | SELLAS Life Sciences Group, Inc. | 2.82B | - | 1,432,374 | - |
| 82 | NRIX | Nurix Therapeutics, Inc. | 2.72B | 0.38% | 193,357 | 36.77M |
| 83 | MLYS | Mineralys Therapeutics, Inc. | 2.72B | -1.12% | 299,026 | - |
| 84 | ATAI | AtaiBeckley Inc. | 2.72B | 0.62% | 1,041,712 | 4.47M |
| 85 | PHVS | Pharvaris N.V. | 2.63B | -0.92% | 187,254 | - |
| 86 | VRDN | Viridian Therapeutics, Inc. | 2.62B | -0.37% | 202,001 | 71.13M |
| 87 | BEAM | Beam Therapeutics Inc. | 2.56B | -4.40% | 681,161 | 156.04M |
| 88 | NKTR | Nektar Therapeutics | 2.53B | -1.69% | 207,319 | 54.59M |
| 89 | VERA | Vera Therapeutics, Inc. | 2.49B | -2.13% | 135,518 | - |
| 90 | HRMY | Harmony Biosciences Holdings, Inc. | 2.44B | -0.59% | 367,262 | 959.90M |
| 91 | OCUL | Ocular Therapeutix, Inc. | 2.43B | -2.59% | 390,574 | 52.06M |
| 92 | PGEN | Precigen, Inc. | 2.42B | -1.75% | 353,880 | 85.72M |
| 93 | TRVI | Trevi Therapeutics, Inc. | 2.38B | -0.71% | 187,564 | - |
| 94 | SRPT | Sarepta Therapeutics, Inc. | 2.37B | 7.35% | 1,400,569 | 1.97B |
| 95 | NUVB | Nuvation Bio Inc. | 2.32B | -0.15% | 375,340 | 169.90M |
| 96 | URGN | UroGen Pharma Ltd. | 2.26B | 5.33% | 245,131 | 188.73M |
| 97 | BHVN | Biohaven Ltd. | 2.22B | - | 285,291 | - |
| 98 | PVLA | Palvella Therapeutics, Inc. | 2.21B | 0.53% | 33,316 | - |
| 99 | KOD | Kodiak Sciences Inc. | 2.18B | -1.11% | 118,527 | - |
| 100 | RAPP | Rapport Therapeutics, Inc. | 2.15B | -2.67% | 63,116 | 20.00M |
| 101 | AUPH | Aurinia Pharmaceuticals Inc. | 2.15B | 0.62% | 135,295 | 311.51M |
| 102 | ZBIO | Zenas BioPharma, Inc. | 2.14B | -0.76% | 39,050 | 1.00M |
| 103 | ADMA | ADMA Biologics, Inc. | 2.11B | -1.15% | 248,635 | 512.28M |
| 104 | MESO | Mesoblast Limited | 2.08B | -2.44% | 47,648 | 120.25M |
| 105 | AGIO | Agios Pharmaceuticals, Inc. | 2.06B | 3.07% | 239,294 | 98.34M |
| 106 | KLRA | Kailera Therapeutics, Inc. | 2.06B | -3.29% | 90,940 | - |
| 107 | COAG | Hemab Therapeutics Holdings, Inc. | 2.06B | -1.17% | 73,175 | - |
| 108 | GENB | Generate Biomedicines, Inc. | 2.01B | -1.45% | 174,892 | 26.48M |
| 109 | VCEL | Vericel Corporation | 1.98B | -0.82% | 41,096 | 306.30M |
| 110 | ZYME | Zymeworks Inc. | 1.97B | -1.25% | 34,119 | 37.13M |
| 111 | STOK | Stoke Therapeutics, Inc. | 1.92B | -1.06% | 84,056 | 27.59M |
| 112 | NBTX | Nanobiotix S.A. | 1.92B | -5.55% | 13,134 | 38.27M |
| 113 | KARD | Kardigan, Inc. | 1.91B | -5.56% | 54,817 | - |
| 114 | XNCR | Xencor, Inc. | 1.88B | -0.32% | 214,682 | 104.97M |
| 115 | BRVE | Braveheart Bio, Inc. | 1.86B | -1.26% | 34,561 | - |
| 116 | GHRS | GH Research PLC | 1.86B | -2.48% | 40,752 | - |
| 117 | VIR | Vir Biotechnology, Inc. | 1.86B | -1.79% | 299,849 | 303.23M |
| 118 | INBX | Inhibrx Biosciences, Inc. | 1.84B | 9.07% | 188,901 | 1.30M |
| 119 | LKFT | Lakefront Biotherapeutics NV | 1.82B | -0.14% | 41,276 | 1.13B |
| 120 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.82B | -2.78% | 447,228 | 208.78M |
| 121 | IMCR | Immunocore Holdings plc | 1.79B | -1.53% | 17,460 | 430.78M |
| 122 | SEPN | Septerna, Inc. | 1.79B | 2.46% | 67,320 | 98.88M |
| 123 | RXRX | Recursion Pharmaceuticals, Inc. | 1.79B | -3.20% | 2,195,644 | 54.86M |
| 124 | SNDX | Syndax Pharmaceuticals, Inc. | 1.78B | -0.10% | 258,037 | 252.25M |
| 125 | TSHA | Taysha Gene Therapies, Inc. | 1.74B | -2.46% | 288,031 | 5.49M |
| 126 | NTLA | Intellia Therapeutics, Inc. | 1.73B | -2.90% | 1,494,894 | 59.51M |
| 127 | DMRA | Damora Therapeutics, Inc. | 1.69B | -6.10% | 45,378 | - |
| 128 | ANAB | AnaptysBio, Inc. | 1.67B | -0.44% | 50,282 | 232.39M |
| 129 | AVLN | Avalyn Pharma Inc. | 1.64B | -1.75% | 40,593 | - |
| 130 | NVAX | Novavax, Inc. | 1.63B | -3.04% | 1,127,868 | 413.80M |
| 131 | FTRE | Fortrea Holdings Inc. | 1.61B | -0.76% | 237,751 | 2.68B |
| 132 | AAPG | Ascentage Pharma Group International | 1.60B | - | 30 | 94.61M |
| 133 | APMD | Apnimed, Inc. | 1.58B | -0.89% | 48,542 | 120.15M |
| 134 | BCAX | Bicara Therapeutics Inc. | 1.58B | 0.42% | 61,677 | - |
| 135 | LBRX | LB Pharmaceuticals Inc | 1.57B | -1.40% | 32,900 | - |
| 136 | LTGO | Latigo Biotherapeutics, Inc. | 1.56B | -0.97% | 25,109 | - |
| 137 | INVA | Innoviva, Inc. | 1.53B | -0.61% | 49,132 | 440.00M |
| 138 | TRAX | First Tracks Biotherapeutics, Inc. | 1.50B | 0.28% | 50,633 | - |
| 139 | ABSI | Absci Corporation | 1.49B | -2.47% | 385,207 | 1.56M |
| 140 | SLBT | SL Science Holding Limited | 1.49B | -0.38% | 15,940 | 3.27M |
| 141 | AVBP | ArriVent BioPharma, Inc. | 1.47B | -1.75% | 23,801 | - |
| 142 | RARE | Ultragenyx Pharmaceutical Inc. | 1.45B | -1.01% | 618,976 | 717.00M |
| 143 | MAZE | Maze Therapeutics, Inc. | 1.43B | -2.54% | 75,156 | 20.00M |
| 144 | ANRO | Alto Neuroscience, Inc. | 1.41B | 0.42% | 46,781 | - |
| 145 | VOR | Vor Biopharma Inc. | 1.40B | -5.58% | 220,370 | - |
| 146 | OMER | Omeros Corporation | 1.38B | 0.05% | 179,477 | 38.42M |
| 147 | CGEM | Cullinan Therapeutics, Inc. | 1.38B | -1.01% | 280,426 | - |
| 148 | AKTS | Aktis Oncology, Inc. | 1.37B | -1.28% | 60,696 | 10.06M |
| 149 | SVRA | Savara Inc. | 1.37B | -2.62% | 136,889 | - |
| 150 | REPL | Replimune Group, Inc. | 1.35B | -2.91% | 195,964 | - |
| 151 | DRTS | Alpha Tau Medical Ltd. | 1.35B | -1.82% | 75,537 | - |
| 152 | ALMS | Alumis Inc. | 1.32B | -3.88% | 535,823 | 7.40M |
| 153 | MGTX | MeiraGTx Holdings plc | 1.31B | 0.96% | 85,001 | 397.50M |
| 154 | MNKD | MannKind Corporation | 1.29B | -3.37% | 1,506,543 | 393.63M |
| 155 | ORIC | ORIC Pharmaceuticals, Inc. | 1.29B | -1.39% | 181,092 | - |
| 156 | ODTX | Odyssey Therapeutics, Inc. | 1.28B | -0.89% | 23,441 | 99.00K |
| 157 | IMTX | Immatics N.V. | 1.28B | -0.95% | 18,808 | 47.65M |
| 158 | SPTX | Seaport Therapeutics, Inc. | 1.27B | -1.45% | 145,005 | - |
| 159 | JBIO | Jade Biosciences, Inc. | 1.25B | 0.98% | 452,903 | - |
| 160 | TYRA | Tyra Biosciences, Inc. | 1.25B | -21.70% | 2,044,587 | - |
| 161 | MLTX | MoonLake Immunotherapeutics | 1.22B | -3.82% | 266,960 | - |
| 162 | JANX | Janux Therapeutics, Inc. | 1.22B | -0.50% | 57,425 | 24.00M |
| 163 | GLUE | Monte Rosa Therapeutics, Inc. | 1.22B | 0.07% | 166,525 | 28.73M |
| 164 | OBX | Obsidian Therapeutics, Inc. | 1.19B | 2.83% | 44,915 | - |
| 165 | ATTO | Attovia Therapeutics, Inc. | 1.16B | 7.78% | 35,445 | 1.80M |
| 166 | CRVS | Corvus Pharmaceuticals, Inc. | 1.12B | -4.52% | 180,518 | - |
| 167 | IVA | Inventiva S.A. | 1.11B | -4.39% | 272,090 | 7.94M |
| 168 | KURA | Kura Oncology, Inc. | 1.09B | -2.16% | 440,328 | 77.23M |
| 169 | SLDB | Solid Biosciences Inc. | 1.05B | -1.71% | 115,329 | - |
| 170 | AVTX | Avalo Therapeutics, Inc. | 1.03B | -2.28% | 95,809 | 59.00K |
| 171 | ABUS | Arbutus Biopharma Corporation | 1.03B | 0.39% | 618,223 | 181.72M |
| 172 | SANA | Sana Biotechnology, Inc. | 1.00B | -2.90% | 602,415 | - |
| 173 | ANL | Adlai Nortye Group Ltd. | 994.30M | -0.45% | 39,542 | 18.06M |
| 174 | FTH | Faeth Therapeutics, Inc. | 990.59M | -2.21% | 34,690 | - |
| 175 | LXRX | Lexicon Pharmaceuticals, Inc. | 981.13M | -1.12% | 417,637 | 41.47M |
| 176 | DSGN | Design Therapeutics, Inc. | 958.13M | 0.53% | 127,220 | - |
| 177 | WVE | Wave Life Sciences, Inc. | 955.68M | -1.22% | 342,800 | 65.37M |
| 178 | CADL | Candel Therapeutics, Inc. | 952.27M | -1.23% | 80,374 | - |
| 179 | GERN | Geron Corporation | 938.01M | -3.31% | 1,215,396 | 204.56M |
| 180 | SGP | SpyGlass Pharma, Inc. | 936.88M | -3.15% | 22,321 | - |
| 181 | OLMA | Olema Pharmaceuticals, Inc. | 932.72M | -2.96% | 110,915 | - |
| 182 | HELP | Cybin Inc. | 923.48M | 2.02% | 259,651 | - |
| 183 | ARDX | Ardelyx, Inc. | 923.24M | -1.72% | 375,955 | 450.89M |
| 184 | IMMX | Immix Biopharma, Inc. | 920.71M | -2.87% | 263,658 | - |
| 185 | CLYM | Climb Bio, Inc. | 912.09M | -0.13% | 466,996 | - |
| 186 | RIGL | Rigel Pharmaceuticals, Inc. | 886.73M | 0.21% | 12,394 | 276.79M |
| 187 | TBPH | Theravance Biopharma, Inc. | 886.51M | 0.09% | 17,608 | 104.31M |
| 188 | CBIO | Crescent Biopharma, Inc. | 866.72M | -1.03% | 73,850 | 11.88M |
| 189 | ACRS | Aclaris Therapeutics, Inc. | 854.49M | -4.21% | 491,592 | 8.22M |
| 190 | ANNX | Annexon, Inc. | 849.31M | -4.07% | 1,085,039 | - |
| 191 | SLN | Silence Therapeutics plc | 836.31M | 1.46% | 58,152 | 615.00K |
| 192 | DBVT | DBV Technologies S.A. | 801.91M | 0.83% | 20,108 | 5.04M |
| 193 | PHAR | Pharming Group N.V. | 799.16M | -2.61% | 4,023 | 366.48M |
| 194 | FDMT | 4D Molecular Therapeutics, Inc. | 788.89M | -2.39% | 81,967 | 92.01M |
| 195 | ACHV | Achieve Life Sciences, Inc. | 785.66M | -2.61% | 701,340 | - |
| 196 | NGNE | Neurogene Inc. | 779.84M | 2.20% | 35,909 | 925.00K |
| 197 | CTMX | CytomX Therapeutics, Inc. | 778.99M | -2.05% | 205,785 | 18.30M |
| 198 | NVCT | Nuvectis Pharma, Inc. | 775.77M | -0.75% | 16,532 | - |
| 199 | MNPR | Monopar Therapeutics Inc. | 772.03M | 0.56% | 26,633 | - |
| 200 | MPLT | MapLight Therapeutics, Inc. | 766.39M | -1.15% | 51,414 | - |
| 201 | AURA | Aura Biosciences, Inc. | 751.34M | -1.56% | 69,734 | - |
| 202 | VSTM | Verastem, Inc. | 742.62M | 1.49% | 676,001 | 87.53M |
| 203 | GYRE | Gyre Therapeutics, Inc. | 742.24M | -2.37% | 22,754 | 109.82M |
| 204 | AGMB | AgomAb Therapeutics NV | 735.27M | 0.13% | 22,497 | - |
| 205 | ZVRA | Zevra Therapeutics, Inc. | 733.39M | -2.56% | 178,585 | 136.07M |
| 206 | OCS | Oculis Holding AG | 729.06M | -2.88% | 25,674 | 1.45M |
| 207 | PHAT | Phathom Pharmaceuticals, Inc. | 704.54M | -5.94% | 276,399 | 239.66M |
| 208 | ASMB | Assembly Biosciences, Inc. | 699.39M | -2.64% | 56,930 | 74.85M |
| 209 | BLSM | BlossomHill Therapeutics, Inc. | 688.26M | -2.05% | 21,770 | - |
| 210 | SGMT | Sagimet Biosciences Inc. | 677.22M | 1.73% | 289,214 | - |
| 211 | MDXG | MiMedx Group, Inc. | 669.04M | -1.71% | 181,739 | 355.17M |
| 212 | DRUG | Bright Minds Biosciences Inc. | 656.68M | -0.54% | 6,408 | - |
| 213 | VALN | Valneva SE | 655.76M | -0.91% | 4,683 | 163.30M |
| 214 | ALT | Altimmune, Inc. | 649.69M | -0.60% | 576,383 | 31.00K |
| 215 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 647.81M | -8.80% | 172,004 | - |
| 216 | STTK | Shattuck Labs, Inc. | 641.32M | -1.69% | 170,123 | 1.00M |
| 217 | CRMD | CorMedix Inc. | 639.92M | 0.37% | 130,681 | 462.25M |
| 218 | ALLO | Allogene Therapeutics, Inc. | 623.61M | -2.96% | 823,123 | 4.64M |
| 219 | EIKN | Eikon Therapeutics, Inc. | 613.15M | 5.70% | 189,523 | - |
| 220 | PRME | Prime Medicine, Inc. | 608.43M | -3.93% | 619,714 | 4.07M |
| 221 | CTNM | Contineum Therapeutics, Inc. | 598.18M | -0.25% | 55,988 | - |
| 222 | TECX | Tectonic Therapeutic, Inc. | 588.83M | -0.92% | 13,647 | - |
| 223 | OABI | OmniAb, Inc. | 585.20M | -5.07% | 262,210 | 38.46M |
| 224 | PROK | ProKidney Corp. | 583.48M | -3.02% | 219,349 | 818.00K |
| 225 | ARVN | Arvinas, Inc. | 583.24M | -1.76% | 183,512 | 316.70M |
| 226 | SCTX | Scribe Therapeutics Inc. | 580.07M | -2.23% | 31,805 | 33.30M |
| 227 | RGNX | REGENXBIO Inc. | 572.99M | -0.91% | 219,801 | 174.48M |
| 228 | ZURA | Zura Bio Limited | 560.60M | -4.57% | 228,528 | - |
| 229 | AUTL | Autolus Therapeutics plc | 549.63M | -2.13% | 536,174 | 117.39M |
| 230 | EPRX | Eupraxia Pharmaceuticals Inc. | 544.68M | -0.12% | 27,398 | - |
| 231 | CABA | Cabaletta Bio, Inc. | 539.15M | -2.75% | 1,111,869 | - |
| 232 | PRLD | Prelude Therapeutics Incorporated | 537.12M | -1.60% | 73,724 | 22.42M |
| 233 | SPRY | ARS Pharmaceuticals, Inc. | 532.04M | -0.74% | 154,090 | 116.93M |
| 234 | OVID | Ovid Therapeutics Inc. | 531.21M | -1.09% | 122,746 | 1.58M |
| 235 | ARTV | Artiva Biotherapeutics, Inc. | 530.46M | -0.28% | 31,759 | 251.00K |
| 236 | CAPR | Capricor Therapeutics, Inc. | 530.23M | 0.66% | 630,426 | 11.13M |
| 237 | IRD | Opus Genetics, Inc. | 527.05M | 45.97% | 27,821,673 | 9.86M |
| 238 | ENTX | Entera Bio Ltd. | 522.89M | 0.33% | 21,605 | 42.00K |
| 239 | KYTX | Kyverna Therapeutics, Inc. | 488.56M | -2.11% | 225,325 | - |
| 240 | PRTA | Prothena Corporation plc | 478.97M | -2.20% | 48,767 | 54.53M |
| 241 | PBYI | Puma Biotechnology, Inc. | 478.52M | -1.28% | 32,302 | 231.24M |
| 242 | DNA | Ginkgo Bioworks Holdings, Inc. | 460.61M | -1.44% | 166,924 | 132.42M |
| 243 | EDIT | Editas Medicine, Inc. | 445.38M | -4.29% | 526,655 | 47.01M |
| 244 | VOGX | Vogenx, Inc. | 444.67M | -0.16% | 8,600 | - |
| 245 | RLMD | Relmada Therapeutics, Inc. | 443.75M | -2.12% | 189,504 | - |
| 246 | IKT | Inhibikase Therapeutics, Inc. | 440.62M | -0.41% | 96,439 | 1.00 |
| 247 | RZLT | Rezolute, Inc. | 438.76M | -4.55% | 337,971 | - |
| 248 | CCCC | C4 Therapeutics, Inc. | 429.97M | -1.55% | 332,085 | 35.04M |
| 249 | AVIR | Atea Pharmaceuticals, Inc. | 428.29M | -5.99% | 133,706 | - |
| 250 | BNTC | Benitec Biopharma Inc. | 422.90M | -3.26% | 5,942 | - |
| 251 | FENC | Fennec Pharmaceuticals Inc. | 420.81M | -3.61% | 71,929 | 59.22M |
| 252 | ARCT | Arcturus Therapeutics Holdings Inc. | 420.66M | -5.31% | 97,515 | 29.37M |
| 253 | VTVT | vTv Therapeutics Inc. | 419.96M | 3.08% | 9,127 | 36.84M |
| 254 | GALT | Galectin Therapeutics Inc. | 418.53M | 0.24% | 38,284 | - |
| 255 | LRMR | Larimar Therapeutics, Inc. | 406.57M | -4.42% | 204,518 | - |
| 256 | TTRX | Turn Therapeutics Inc. | 405.12M | 7.42% | 58,827 | - |
| 257 | RCKT | Rocket Pharmaceuticals, Inc. | 403.97M | -0.81% | 250,010 | - |
| 258 | EVMN | Evommune, Inc. | 401.03M | -15.52% | 1,709,998 | 10.00M |
| 259 | CMPX | Compass Therapeutics, Inc. | 397.09M | -0.23% | 572,251 | 850.00K |
| 260 | ENTA | Enanta Pharmaceuticals, Inc. | 387.08M | -1.56% | 22,978 | 65.26M |
| 261 | EYPT | EyePoint, Inc. | 381.92M | -2.85% | 464,384 | 2.79M |
| 262 | LXEO | Lexeo Therapeutics, Inc. | 380.68M | -2.52% | 57,248 | - |
| 263 | OCGN | Ocugen, Inc. | 378.11M | -16.17% | 7,361,057 | 4.58M |
| 264 | IPSC | Century Therapeutics, Inc. | 370.30M | -1.21% | 54,025 | 109.16M |
| 265 | ZNTL | Zentalis Pharmaceuticals, Inc. | 370.17M | -2.98% | 38,110 | 26.87M |
| 266 | PALI | Palisade Bio, Inc. | 369.45M | -3.64% | 361,475 | 500.00K |
| 267 | DMAC | DiaMedica Therapeutics Inc. | 365.08M | 3.52% | 54,265 | - |
| 268 | XFOR | X4 Pharmaceuticals, Inc. | 347.01M | -0.14% | 231,044 | 15.85M |
| 269 | QTTB | Q32 Bio Inc. | 344.73M | -0.94% | 97,721 | 53.74M |
| 270 | SION | Sionna Therapeutics, Inc. | 335.48M | 1.64% | 101,799 | - |
| 271 | VCRE | Vicore Pharma Holding AB (publ) | 335.45M | -0.50% | 1,778 | 412.09K |
| 272 | SABS | SAB Biotherapeutics, Inc. | 332.10M | 0.55% | 34,379 | 114.70K |
| 273 | PYXS | Pyxis Oncology, Inc. | 331.13M | 2.06% | 916,988 | 11.04M |
| 274 | AGEN | Agenus Inc. | 328.65M | -1.75% | 215,354 | 132.69M |
| 275 | UPB | Upstream Bio, Inc. | 328.63M | -3.07% | 70,122 | 3.16M |
| 276 | ABEO | Abeona Therapeutics Inc. | 328.24M | -1.88% | 272,841 | 25.52M |
| 277 | LYEL | Lyell Immunopharma, Inc. | 327.63M | -1.18% | 18,152 | 27.00K |
| 278 | OBIO | Orchestra BioMed Holdings, Inc. | 323.37M | -0.92% | 19,933 | 31.98M |
| 279 | VNDA | Vanda Pharmaceuticals Inc. | 316.82M | -1.69% | 149,701 | 215.72M |
| 280 | STRO | Sutro Biopharma, Inc. | 312.22M | -1.41% | 14,985 | 45.70M |
| 281 | IFRX | InflaRx N.V. | 310.95M | -2.76% | 54,887 | -11.54K |
| 282 | IMRX | Immuneering Corporation | 307.31M | -0.63% | 281,322 | - |
| 283 | INDP | Indaptus Therapeutics, Inc. | 303.79M | 23.24% | 3,021,206 | - |
| 284 | CUVL | Clinuvel Pharmaceuticals Limited | 297.17M | -1.50% | 7,130 | 65.05M |
| 285 | FATE | Fate Therapeutics, Inc. | 296.56M | -1.00% | 114,178 | 6.49M |
| 286 | PRQR | ProQR Therapeutics N.V. | 292.12M | 0.98% | 140,790 | 21.05M |
| 287 | FULC | Fulcrum Therapeutics, Inc. | 289.17M | -0.79% | 143,577 | 80.00M |
| 288 | BCYC | Bicycle Therapeutics plc | 287.67M | -1.67% | 85,500 | 61.21M |
| 289 | YDES | YD Bio Limited | 285.50M | -4.47% | 187,854 | 510.36K |
| 290 | FHTX | Foghorn Therapeutics Inc. | 284.46M | -0.83% | 38,190 | 36.74M |
| 291 | CAMP | Camp4 Therapeutics Corporation | 279.25M | 1.14% | 8,440 | 4.22M |
| 292 | ACIU | AC Immune SA | 278.40M | 0.72% | 70,064 | 21.67M |
| 293 | ALXO | ALX Oncology Holdings Inc. | 273.10M | -1.25% | 165,628 | - |
| 294 | MGNX | MacroGenics, Inc. | 265.63M | -3.47% | 79,773 | 175.14M |
| 295 | ALEC | Alector, Inc. | 265.19M | -3.85% | 68,202 | 13.86M |
| 296 | RNAC | Cartesian Therapeutics, Inc. | 263.83M | -2.57% | 19,067 | 1.48M |
| 297 | LCTX | Lineage Cell Therapeutics, Inc. | 263.02M | -4.59% | 536,296 | 13.08M |
| 298 | AVXL | Anavex Life Sciences Corp. | 260.94M | -1.23% | 76,554 | - |
| 299 | TRDA | Entrada Therapeutics, Inc. | 257.81M | -4.92% | 35,848 | 4.69M |
| 300 | WHWK | Whitehawk Therapeutics, Inc. | 245.14M | -2.05% | 30,034 | 7.15M |
| 301 | CGEN | Compugen Ltd. | 239.65M | -1.17% | 30,205 | 74.00M |
| 302 | CLLS | Cellectis S.A. | 238.44M | -1.90% | 2,320 | 63.82M |
| 303 | NGEN | NervGen Pharma Corp. | 236.01M | 0.23% | 75,857 | - |
| 304 | ELDN | Eledon Pharmaceuticals, Inc. | 234.26M | -1.71% | 159,384 | - |
| 305 | NMRA | Neumora Therapeutics, Inc. | 232.99M | -0.80% | 96,647 | - |
| 306 | IVVD | Invivyd, Inc. | 232.86M | -4.34% | 456,484 | 58.37M |
| 307 | GLSI | Greenwich LifeSciences, Inc. | 232.21M | -0.50% | 13,999 | - |
| 308 | SRZN | Surrozen, Inc. | 232.13M | -4.50% | 25,745 | 11.51M |
| 309 | VRXA | Veraxa Biotech AG | 231.91M | 2.50% | 70,597 | 29.54K |
| 310 | TARA | Protara Therapeutics, Inc. | 229.88M | - | 81,363 | - |
| 311 | KROS | Keros Therapeutics, Inc. | 227.32M | 2.64% | 43,639 | 15.01M |
| 312 | ADAG | Adagene Inc. | 227.28M | -3.01% | 62,066 | 9.29M |
| 313 | SLGL | Sol-Gel Technologies Ltd. | 227.02M | -0.04% | 14,334 | 1.80M |
| 314 | PEPG | PepGen Inc. | 226.82M | 2.02% | 371,237 | - |
| 315 | NKTX | Nkarta, Inc. | 223.47M | -3.41% | 235,053 | - |
| 316 | CUE | Cue Biopharma, Inc. | 223.02M | 2.33% | 18,680 | 37.66M |
| 317 | TNXP | Tonix Pharmaceuticals Holding Corp. | 221.42M | -1.90% | 31,645 | 29.10M |
| 318 | ANTX | AN2 Therapeutics, Inc. | 221.13M | -2.01% | 18,741 | - |
| 319 | ABOS | Acumen Pharmaceuticals, Inc. | 216.95M | -5.06% | 126,211 | - |
| 320 | ACOG | Alpha Cognition Inc. | 211.27M | 1.90% | 804 | 15.26M |
| 321 | PLX | Protalix BioTherapeutics, Inc. | 211.10M | -1.13% | 148,191 | 80.62M |
| 322 | ARMP | Armata Pharmaceuticals, Inc. | 210.08M | -2.92% | 2,573 | 5.54M |
| 323 | CHRS | Coherus Oncology, Inc. | 207.80M | -1.82% | 203,142 | 50.94M |
| 324 | NERV | Minerva Neurosciences, Inc. | 205.31M | -1.60% | 7,480 | - |
| 325 | DTIL | Precision BioSciences, Inc. | 201.77M | -1.22% | 38,901 | 45.06M |
| 326 | KRRO | Korro Bio, Inc. | 201.59M | 1.33% | 17,173 | 2.38M |
| 327 | VYGR | Voyager Therapeutics, Inc. | 201.49M | -3.82% | 75,194 | 34.46M |
| 328 | ORMP | Oramed Pharmaceuticals Inc. | 199.25M | -3.82% | 39,778 | 2.00M |
| 329 | NBP | NovaBridge Biosciences | 197.78M | -4.21% | 60,358 | - |
| 330 | MSLE | Satellos Bioscience Inc. | 196.67M | 0.98% | 9,519 | - |
| 331 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 190.71M | -6.94% | 182,910 | - |
| 332 | IPHA | Innate Pharma S.A. | 186.80M | -2.68% | 5,787 | 10.57M |
| 333 | RNA | Atrium Therapeutics, Inc. | 181.15M | -6.70% | 240,727 | 35.84M |
| 334 | CNTN | Canton Strategic Holdings, Inc. | 179.28M | 0.90% | 109,822 | 1.50M |
| 335 | MDWD | MediWound Ltd. | 174.16M | 0.37% | 23,781 | 11.86M |
| 336 | IMUX | Immunic, Inc. | 169.60M | -2.43% | 40,808 | - |
| 337 | KZIA | Kazia Therapeutics Limited | 169.24M | 2.83% | 82,296 | 1.27M |
| 338 | SPRB | Spruce Biosciences, Inc. | 164.97M | -2.86% | 50,774 | 697.00K |
| 339 | LENZ | LENZ Therapeutics, Inc. | 163.70M | -2.25% | 81,734 | 21.48M |
| 340 | MENS | Jyong Biotech Ltd. | 162.20M | 3.07% | 10,119 | - |
| 341 | HUMA | Humacyte, Inc. | 161.96M | -2.00% | 684,969 | 2.12M |
| 342 | MOLN | Molecular Partners AG | 161.96M | - | 106 | 856.30K |
| 343 | CRBU | Caribou Biosciences, Inc. | 160.28M | -2.92% | 555,760 | 10.04M |
| 344 | EQ | Equillium, Inc. | 157.89M | 3.32% | 64,743 | 4.39M |
| 345 | MIST | Milestone Pharmaceuticals Inc. | 157.82M | -0.44% | 323,026 | 2.34M |
| 346 | CDXS | Codexis, Inc. | 156.05M | -0.35% | 80,569 | 77.68M |
| 347 | OTLK | Outlook Therapeutics, Inc. | 151.81M | -2.64% | 993,701 | -1.16M |
| 348 | TNYA | Tenaya Therapeutics, Inc. | 150.23M | 0.99% | 446,339 | 1.34M |
| 349 | NRXP | NRx Pharmaceuticals, Inc. | 148.39M | -1.15% | 143,204 | 3.39M |
| 350 | INO | Inovio Pharmaceuticals, Inc. | 143.21M | -2.46% | 522,440 | 65.34K |
| 351 | UNCY | Unicycive Therapeutics, Inc. | 140.81M | 0.50% | 306,543 | - |
| 352 | OKUR | OnKure Therapeutics, Inc. | 135.66M | -1.47% | 9,427 | - |
| 353 | BMEA | Biomea Fusion, Inc. | 133.37M | -4.66% | 636,071 | - |
| 354 | HURA | TuHURA Biosciences, Inc. | 132.55M | -1.89% | 26,068 | - |
| 355 | TLSA | Tiziana Life Sciences Ltd | 128.66M | 0.54% | 74,973 | - |
| 356 | ENGN | enGene Therapeutics Inc. | 127.96M | -0.52% | 171,225 | - |
| 357 | CNXU | Conexeu Sciences Inc. | 125.50M | 0.21% | 49,112 | - |
| 358 | CNTB | Connect Biopharma Holdings Limited | 122.80M | 2.09% | 207,941 | 2.95M |
| 359 | TENX | Tenax Therapeutics, Inc. | 122.58M | 8.08% | 4,002,845 | - |
| 360 | NAUT | Nautilus Biotechnology, Inc. | 122.48M | 3.73% | 343,671 | 190.00K |
| 361 | VANI | Vivani Medical, Inc. | 121.77M | -0.37% | 124,376 | - |
| 362 | CBUS | Cibus, Inc. | 121.52M | -1.24% | 17,613 | 4.35M |
| 363 | BDTX | Black Diamond Therapeutics, Inc. | 120.08M | -0.48% | 94,705 | 70.00M |
| 364 | RANI | Rani Therapeutics Holdings, Inc. | 118.49M | -2.58% | 54,552 | 4.88M |
| 365 | PMN | ProMIS Neurosciences, Inc. | 115.23M | 2.55% | 13,139 | - |
| 366 | GNLX | Genelux Corporation | 112.93M | -0.79% | 17,932 | 8.00K |
| 367 | GUTS | Fractyl Health, Inc. | 111.43M | 2.16% | 274,206 | 3.00K |
| 368 | AARD | Aardvark Therapeutics, Inc. | 109.21M | -6.38% | 12,527 | - |
| 369 | SEER | Seer, Inc. | 107.98M | - | 11,748 | 14.22M |
| 370 | COYA | Coya Therapeutics, Inc. | 107.08M | -0.98% | 22,164 | 8.02M |
| 371 | PYPD | PolyPid Ltd. | 106.03M | -2.06% | 68,305 | - |
| 372 | ACET | Adicet Bio, Inc. | 104.95M | 0.21% | 24,639 | - |
| 373 | ONCY | Oncolytics Biotech Inc. | 103.67M | 0.99% | 187,244 | - |
| 374 | ATRA | Atara Biotherapeutics, Inc. | 103.59M | 0.88% | 11,290 | 6.19M |
| 375 | PMVP | PMV Pharmaceuticals, Inc. | 103.45M | 2.24% | 36,240 | - |
| 376 | PLYX | Polaryx Therapeutics, Inc. | 101.69M | 0.99% | 13,471 | - |
| 377 | CGTX | Cognition Therapeutics, Inc. | 96.04M | - | 21,675 | - |
| 378 | ANIX | Anixa Biosciences, Inc. | 95.26M | -3.45% | 269,461 | - |
| 379 | RNXT | RenovoRx, Inc. | 95.22M | -4.09% | 202,871 | 1.98M |
| 380 | PTHS | Pelthos Therapeutics Inc. | 93.07M | -0.98% | 19,845 | 43.30M |
| 381 | ALDX | Aldeyra Therapeutics, Inc. | 91.09M | -1.95% | 145,282 | - |
| 382 | VRCA | Verrica Pharmaceuticals Inc. | 90.19M | -0.19% | 9,521 | 30.32M |
| 383 | ICCC | ImmuCell Corporation | 88.91M | -0.51% | 1,560 | 30.68M |
| 384 | FBIO | Fortress Biotech, Inc. | 88.71M | -1.85% | 79,456 | 68.47M |
| 385 | ACRV | Acrivon Therapeutics, Inc. | 88.28M | -1.90% | 57,302 | - |
| 386 | MNOV | MediciNova, Inc. | 87.86M | 2.00% | 60,141 | 920.48K |
| 387 | RLYB | Rallybio Corporation | 87.84M | -0.42% | 2,552 | 646.00K |
| 388 | NTHI | NeOnc Technologies Holdings, Inc. | 87.00M | -14.00% | 135,097 | 39.99K |
| 389 | KLRS | Kalaris Therapeutics, Inc. | 85.70M | -0.83% | 20,791 | - |
| 390 | OSTX | OS Therapies Incorporated | 83.95M | -0.55% | 127,474 | - |
| 391 | IBIO | iBio, Inc. | 82.63M | -1.15% | 216,108 | 100.00K |
| 392 | TELO | Telomir Pharmaceuticals, Inc. | 81.84M | - | 1,565 | - |
| 393 | CRDF | Cardiff Oncology, Inc. | 81.69M | -4.55% | 177,302 | 508.00K |
| 394 | MAIA | MAIA Biotechnology, Inc. | 80.90M | 1.53% | 132,811 | - |
| 395 | GOSS | Gossamer Bio, Inc. | 78.85M | -10.34% | 13,546,486 | 53.29M |
| 396 | OKYO | OKYO Pharma Limited | 78.19M | -2.61% | 3,695 | - |
| 397 | GANX | Gain Therapeutics, Inc. | 78.12M | -2.19% | 82,557 | - |
| 398 | CING | Cingulate Inc. | 77.00M | 2.02% | 30,346 | - |
| 399 | ATHE | Alterity Therapeutics Limited | 76.53M | -0.22% | 2,259 | 2.50M |
| 400 | YARW | Yarrow Bioscience, Inc. | 76.48M | -6.77% | 16,356 | - |
| 401 | BSEM | BioStem Technologies, Inc. | 75.68M | 6.00% | 35,529 | 34.59M |
| 402 | LONA | LeonaBio, Inc. | 73.49M | -2.74% | 44,261 | - |
| 403 | RNTX | Rein Therapeutics Inc. | 73.28M | -1.52% | 117,412 | - |
| 404 | NTRB | Nutriband Inc. | 72.81M | -1.80% | 9,433 | 1.62M |
| 405 | NRXS | NeurAxis, Inc. | 72.33M | -2.54% | 15,914 | 5.32M |
| 406 | PLRX | Pliant Therapeutics, Inc. | 71.21M | 1.32% | 97,874 | - |
| 407 | SPRO | Spero Therapeutics, Inc. | 69.88M | 0.84% | 47,447 | 47.00M |
| 408 | CSBR | Champions Oncology, Inc. | 69.47M | -0.99% | 3,872 | 59.43M |
| 409 | INMB | INmune Bio Inc. | 69.38M | -0.40% | 84,837 | 50.00K |
| 410 | ELOX | Eloxx Pharmaceuticals, Inc. | 68.62M | 5.13% | 6,266 | - |
| 411 | DWTX | Dogwood Therapeutics, Inc. | 67.99M | -1.96% | 15,592 | - |
| 412 | EDSA | Edesa Biotech, Inc. | 67.15M | 5.07% | 10,147 | - |
| 413 | XBIT | XBiotech Inc. | 66.51M | 0.06% | 8,025 | - |
| 414 | BOLD | Boundless Bio, Inc. | 65.40M | 0.52% | 4,917 | - |
| 415 | SER | Serina Therapeutics, Inc. | 65.03M | 2.40% | 192,234 | 130.00K |
| 416 | ALPS | Alps Group Inc | 64.06M | - | 61 | 3.74M |
| 417 | HRTX | Heron Therapeutics, Inc. | 62.65M | -5.71% | 393,724 | 151.18M |
| 418 | HYFT | MindWalk Holdings Corp. | 62.49M | -1.48% | 29,936 | 11.43M |
| 419 | EXOZ | eXoZymes, Inc. | 62.42M | 6.58% | 2,614 | -700.00 |
| 420 | ELTX | Elicio Therapeutics, Inc. | 60.19M | -2.55% | 86,526 | - |
| 421 | XLO | Xilio Therapeutics, Inc. | 59.62M | 1.68% | 508 | 64.09M |
| 422 | INKT | MiNK Therapeutics, Inc. | 58.86M | 0.74% | 2,512 | - |
| 423 | IMA | ImageneBio, Inc. | 58.23M | 1.58% | 2,941 | 800.00K |
| 424 | HYPD | Hyperion DeFi, Inc. | 58.12M | 4.47% | 177,954 | 1.40M |
| 425 | IBO | Impact BioMedical Inc. | 54.99M | 2.00% | 16,885 | 35.00K |
| 426 | MCRB | Seres Therapeutics, Inc. | 54.88M | -0.72% | 4,768 | 1.88M |
| 427 | ANVS | Annovis Bio, Inc. | 54.11M | -2.31% | 388,514 | - |
| 428 | APLM | Apollomics, Inc. | 53.80M | - | 1,377 | 8.84M |
| 429 | TIL | Instil Bio, Inc. | 51.95M | -2.05% | 617 | - |
| 430 | IMMP | Immutep Limited | 48.96M | -1.45% | 23,372 | 13.79M |
| 431 | HOWL | Werewolf Therapeutics, Inc. | 47.62M | -0.02% | 92,438 | 21.00M |
| 432 | ATYR | aTyr Pharma, Inc. | 46.59M | -1.21% | 187,607 | 190.00K |
| 433 | TVGN | Tevogen Inc. | 46.23M | -3.14% | 141 | - |
| 434 | MGX | Metagenomi Therapeutics, Inc. | 44.20M | 0.86% | 74,341 | 13.56M |
| 435 | CELU | Celularity Inc. | 44.00M | -1.30% | 48,589 | 26.55M |
| 436 | GRCE | Grace Therapeutics, Inc. | 43.97M | -1.42% | 43,018 | - |
| 437 | VERU | Veru Inc. | 43.48M | -1.16% | 79,827 | 16.89M |
| 438 | MREO | Mereo BioPharma Group plc | 40.07M | -1.45% | 226,497 | 500.00K |
| 439 | ATNM | Actinium Pharmaceuticals, Inc. | 38.99M | 0.81% | 174,854 | 35.09M |
| 440 | KPTI | Karyopharm Therapeutics Inc. | 38.56M | -1.16% | 96,652 | 146.62M |
| 441 | CRVO | CervoMed Inc. | 38.02M | -0.59% | 53,388 | 331.30K |
| 442 | FLNA | Filana Therapeutics, Inc. | 37.69M | -2.14% | 41,394 | - |
| 443 | NXTC | NextCure, Inc. | 37.63M | -2.38% | 8,752 | - |
| 444 | ALGS | Aligos Therapeutics, Inc. | 36.09M | 0.35% | 5,065 | 31.52M |
| 445 | LITS | Lite Strategy, Inc. | 35.39M | -5.45% | 117,836 | - |
| 446 | CNTX | Context Therapeutics Inc. | 34.51M | -0.19% | 274,301 | - |
| 447 | KYNB | Kyntra Bio, Inc. | 33.41M | 0.36% | 1,084 | 4.62M |
| 448 | ACTU | Actuate Therapeutics, Inc. | 32.90M | - | 31,940 | - |
| 449 | BRNS | Barinthus Biotherapeutics plc | 32.68M | 8.09% | - | 14.97M |
| 450 | RNAZ | TransCode Therapeutics, Inc. | 31.15M | -2.65% | 8,611 | - |
| 451 | BCTX | BriaCell Therapeutics Corp. | 30.63M | 1.54% | 13,673 | - |
| 452 | IGC | IGC Pharma, Inc. | 30.35M | 1.28% | 87,336 | 1.11M |
| 453 | QNCX | Quince Therapeutics, Inc. | 29.63M | -1.25% | 3,597 | - |
| 454 | ESLA | Estrella Immunopharma, Inc. | 29.58M | 6.20% | 9,987 | - |
| 455 | QNTM | Quantum BioPharma Ltd. | 29.52M | 10.94% | 119,149 | - |
| 456 | CVM | CEL-SCI Corporation | 29.11M | 0.30% | 29,754 | - |
| 457 | RADX | Radiopharm Theranostics Limited | 28.19M | 5.66% | 52,770 | 9.34M |
| 458 | EVAX | Evaxion A/S | 27.36M | 3.47% | 20,116 | 7.49M |
| 459 | ABVC | ABVC BioPharma, Inc. | 26.44M | -3.77% | 41,235 | 797.92K |
| 460 | BYSI | BeyondSpring Inc. | 25.54M | 0.16% | 12,507 | 1.88M |
| 461 | TVRD | Tvardi Therapeutics, Inc. | 25.34M | -2.06% | 31,418 | - |
| 462 | NNVC | NanoViricides, Inc. | 25.17M | 2.31% | 81,609 | - |
| 463 | ATOS | Atossa Therapeutics, Inc. | 25.05M | -0.20% | 7,853 | - |
| 464 | GRDX | GridAI Technologies Corp. | 23.72M | 4.69% | 4,802 | - |
| 465 | COCP | Cocrystal Pharma, Inc. | 23.50M | 3.39% | 27,751 | 330.00K |
| 466 | PLRZ | Polyrizon Ltd. | 23.46M | - | 6,360 | - |
| 467 | JSPR | Jasper Therapeutics, Inc. | 23.34M | -1.14% | 6,591 | - |
| 468 | CLRB | Cellectar Biosciences, Inc. | 22.97M | 0.83% | 7,424 | - |
| 469 | TCRX | TScan Therapeutics, Inc. | 22.94M | -1.86% | 140,332 | 7.11M |
| 470 | GNTA | Genenta Science S.p.A. | 22.65M | -3.14% | 67,691 | - |
| 471 | LTRN | Lantern Pharma Inc. | 22.63M | -3.80% | 36,321 | - |
| 472 | AKTX | Akari Therapeutics, Plc | 22.12M | 3.65% | 34,673 | - |
| 473 | MRKR | Marker Therapeutics, Inc. | 21.84M | 2.34% | 31,966 | 3.55M |
| 474 | LGVN | Longeveron Inc. | 20.76M | -2.11% | 11,859 | 1.19M |
| 475 | PTN | Palatin Technologies, Inc. | 20.68M | -7.01% | 8,845 | 12.88M |
| 476 | ALLR | Allarity Therapeutics, Inc. | 20.37M | 2.40% | 15,874 | 345.00K |
| 477 | CMMB | Chemomab Therapeutics Ltd. | 20.29M | 1.81% | 28,322 | - |
| 478 | NEUP | Neuphoria Therapeutics Inc. | 20.21M | -0.27% | 184 | -13.27K |
| 479 | KTTA | Pasithea Therapeutics Corp. | 19.71M | -1.50% | 15,111 | - |
| 480 | CNSY | Cerenome, Inc. | 19.51M | -4.81% | 23,321 | 4.20M |
| 481 | LPCN | Lipocine Inc. | 19.39M | -0.32% | 1,245 | 1.57M |
| 482 | ENLV | Enlivex Ltd. | 19.32M | -0.45% | 57,302 | - |
| 483 | DYAI | Dyadic International, Inc. | 18.77M | -0.98% | 7,420 | 3.80M |
| 484 | NCEL | NewcelX Ltd. | 18.43M | -1.85% | 1,524 | - |
| 485 | NIKI | Niki BioSolutions, Inc. | 18.13M | -1.75% | 6,809 | - |
| 486 | PBM | Psyence Biomedical Ltd. | 17.43M | -3.59% | 14,712 | - |
| 487 | BCDA | BioCardia, Inc. | 16.81M | 0.01% | 13,116 | 3.00K |
| 488 | PDSB | PDS Biotechnology Corporation | 16.80M | 0.03% | 7,029,546 | - |
| 489 | ADIL | Adial Pharmaceuticals, Inc. | 16.49M | -5.56% | 10,494 | - |
| 490 | CTXR | Citius Pharmaceuticals, Inc. | 16.48M | -0.03% | 9,516 | 7.11M |
| 491 | LSTA | Lisata Therapeutics, Inc. | 16.40M | -2.15% | 16,480 | 100.00K |
| 492 | TPST | Tempest Therapeutics, Inc. | 15.74M | -0.23% | 23,937 | - |
| 493 | NRSN | NeuroSense Therapeutics Ltd. | 15.53M | 0.45% | 22,842 | - |
| 494 | MBRX | Moleculin Biotech, Inc. | 15.32M | 4.88% | 148,909 | - |
| 495 | PASG | Passage Bio, Inc. | 14.83M | -4.95% | 96 | - |
| 496 | BIVI | BioVie Inc. | 14.71M | -5.80% | 170,937 | - |
| 497 | HIND | Vyome Holdings, Inc. | 14.67M | - | 1,634 | 129.73K |
| 498 | MLEC | Moolec Science SA | 14.24M | -1.23% | 269 | 7.83M |
| 499 | QNRX | Quoin Pharmaceuticals, Ltd. | 13.92M | -3.08% | 16,370 | - |
| 500 | PLUR | Pluri Inc. | 13.63M | -0.51% | 1,634 | 1.08M |